Matthew Scott Harris

Title: The Innovations of Matthew Scott Harris

Introduction

Matthew Scott Harris is an accomplished inventor based in Gaithersburg, MD. He has made significant contributions to the field of therapeutic regimens, particularly in the management of blood glucose levels and body weight. His innovative approach has the potential to impact the lives of many individuals struggling with obesity and diabetes.

Latest Patents

Harris holds a patent for "Therapeutic regimens and methods for lowering blood glucose and/or body weight using GLP-1R and GCGR balanced agonists." This patent focuses on a once-weekly dosing regimen of a dual GLP-1R and GCGR agonist. The formulations and methods outlined in this patent are designed for the treatment of chronic weight management, obesity, and blood glucose control. The dual agonist peptide product of SEQ ID NO. 1 is a key component of this innovative approach.

Career Highlights

Matthew Scott Harris is currently associated with Spitfire Pharma, Inc., where he continues to develop and refine his groundbreaking ideas. His work is characterized by a commitment to improving health outcomes through innovative therapeutic solutions.

Collaborations

Harris collaborates with talented professionals in his field, including Vyjayanthi Krishnan and Joyce James. These partnerships enhance the research and development efforts at Spitfire Pharma, Inc.

Conclusion

Matthew Scott Harris is a notable inventor whose work in therapeutic regimens is paving the way for advancements in obesity and diabetes management. His contributions are vital to the ongoing efforts to improve health and well-being for many individuals.